These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 25702680)

  • 1. Adaptive splenic radiotherapy for symptomatic splenomegaly management in myeloproliferative disorders.
    Sager O; Beyzadeoglu M; Dincoglan F; Demiral S; Uysal B; Gamsiz H; Akin M; Gundem E; Dirican B
    Tumori; 2015; 101(1):84-90. PubMed ID: 25702680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Splenic irradiation in the palliation of patients with lymphoproliferative and myeloproliferative disorders.
    Paulino AC; Reddy SP
    Am J Hosp Palliat Care; 1996; 13(6):32-5. PubMed ID: 8945101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiotherapy for splenomegaly.
    Mod H; Prasiko G; Jha AK; Chaurasia PP; Srivastava R
    JNMA J Nepal Med Assoc; 2005; 44(159):97-9. PubMed ID: 16554863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Splenic irradiation provides transient palliation for symptomatic splenomegaly associated with primary myelofibrosis: a report on 14 patients.
    Kitanaka A; Takenaka K; Shide K; Miyamoto T; Kondo T; Ozawa K; Kurokawa M; Akashi K; Shimoda K
    Int J Hematol; 2016 Apr; 103(4):423-8. PubMed ID: 26791378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splenic irradiation as palliative treatment for symptomatic splenomegaly due to secondary myelofibrosis: a multi-institutional experience.
    Pistevou-Gombaki K; Zygogianni A; Kantzou I; Kyrgias G; Mystakidou K; Kouvaris J; Klonizakis I; Tsirigotis P; Pappa V; Siakantari M; Eleftheriadis N; Georgakopoulos J; Sarris G; Kelekis N; Kouloulias V
    J BUON; 2015; 20(4):1132-6. PubMed ID: 26416067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low dose palliative radiotherapy for splenomegaly in hematologic disorders.
    Lavrenkov K; Krepel-Volsky S; Levi I; Ariad S
    Leuk Lymphoma; 2012 Mar; 53(3):430-4. PubMed ID: 21848363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Palliative irradiation of the spleen.
    McFarland JT; Kuzma C; Millard FE; Johnstone PA
    Am J Clin Oncol; 2003 Apr; 26(2):178-83. PubMed ID: 12714892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Splenic irradiation for symptomatic splenomegaly associated with myelofibrosis with myeloid metaplasia.
    Elliott MA; Chen MG; Silverstein MN; Tefferi A
    Br J Haematol; 1998 Nov; 103(2):505-11. PubMed ID: 9827926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation therapy for palliation of Eisenmenger's syndrome-associated painful splenomegaly.
    Osorio JI; Watkins JM; Strange C; Jenrette JM
    Radiat Med; 2008 Feb; 26(2):84-7. PubMed ID: 18301984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myelosuppression toxicity of palliative splenic irradiation in myelofibrosis and malignant lymphoma.
    Ishibashi N; Maebayashi T; Aizawa T; Sakaguchi M; Abe O; Saito T; Tanaka Y
    Hematology; 2015 May; 20(4):203-7. PubMed ID: 25131182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Splenic irradiation in myeloid hemopathies: evaluation and toxicity].
    Gonzague-Casabianca L; Bouabdallah R; Cowen D; Alzieu C; Richaud P; Resbeut M
    Cancer Radiother; 1997; 1(3):213-21. PubMed ID: 9295875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-Pharmacologic Management of Splenomegaly for Patients with Myelofibrosis: Is There Any Role for Splenectomy or Splenic Radiation in 2020?
    Sankar K; Pettit K
    Curr Hematol Malig Rep; 2020 Oct; 15(5):391-400. PubMed ID: 32827272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiotherapy of splenomegaly : a palliative treatment option for a benign phenomenon in malignant diseases.
    Kriz J; Micke O; Bruns F; Haverkamp U; Mücke R; Schäfer U; Seegenschmiedt H; Müller RP; Eich HT
    Strahlenther Onkol; 2011 Apr; 187(4):221-4. PubMed ID: 21424304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Splenic irradiation for splenomegaly: A systematic review.
    Zaorsky NG; Williams GR; Barta SK; Esnaola NF; Kropf PL; Hayes SB; Meyer JE
    Cancer Treat Rev; 2017 Feb; 53():47-52. PubMed ID: 28063304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Splenic irradiation in the treatment of patients with chronic myelogenous leukemia or myelofibrosis with myeloid metaplasia. Results of daily and intermittent fractionation with and without concomitant hydroxyurea.
    Wagner H; McKeough PG; Desforges J; Madoc-Jones H
    Cancer; 1986 Sep; 58(6):1204-7. PubMed ID: 2427184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-time splenic irradiation for splenomegaly.
    Schratter-Sehn AU; Cerveny M; Simmel H; Schlögl E; Schratter A
    Onkologie; 2003 Feb; 26(1):21-4. PubMed ID: 12624513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Splenic irradiation in myelofibrosis with myeloid metaplasia: a review.
    Elliott MA; Tefferi A
    Blood Rev; 1999 Sep; 13(3):163-70. PubMed ID: 10527268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Splenic irradiation in the treatment of idiopathic myelofibrosis. Retrospective study of 14 cases].
    Sciascia R; Mazza P; Tondi L
    Radiol Med; 1988; 76(1-2):87-90. PubMed ID: 3399713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Splenic irradiation in hematologic malignancies and other hematologic disorders--single institution experience.
    Soldić Z; Murgić J; Jazvić M; Radić J; Bolanca A; Stancić V; Kusić Z
    Acta Clin Croat; 2011 Mar; 50(1):29-35. PubMed ID: 22034781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modern management of splenomegaly in patients with myelofibrosis.
    Tremblay D; Schwartz M; Bakst R; Patel R; Schiano T; Kremyanskaya M; Hoffman R; Mascarenhas J
    Ann Hematol; 2020 Jul; 99(7):1441-1451. PubMed ID: 32417942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.